Joel Lewis
President and CEO at Galectin Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Galectin Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Galectin Therapeutics Inc. December 3, 202598.0%
-
Galectin Therapeutics Inc. January 23, 202597.3%
-
Galectin Therapeutics Inc. December 7, 202398.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 6, 2026 | Galectin Therapeutics Inc. | Open-market sale | −37,698 | $3.58 | $134,959 |
| Jan 5, 2026 | Galectin Therapeutics Inc. | Open-market sale | −27,731 | $3.91 | $108,428 |
| Jan 2, 2026 | Galectin Therapeutics Inc. | Option exercise | +84,000 | — | — |
| Jan 2, 2026 | Galectin Therapeutics Inc. | Open-market sale | −18,571 | $4.20 | $77,998 |
| Dec 17, 2025 | Galectin Therapeutics Inc. | Option exercise | +7,829 | $2.86 | $22,391 |
| Dec 17, 2025 | Galectin Therapeutics Inc. | Open-market sale | −7,829 | $7.06 | $55,273 |
| Nov 18, 2025 | Galectin Therapeutics Inc. | Option exercise | +6,783 | $2.39 | $16,211 |
| Nov 18, 2025 | Galectin Therapeutics Inc. | Open-market sale | −6,783 | $6.15 | $41,715 |
| Nov 17, 2025 | Galectin Therapeutics Inc. | Option exercise | +15,680 | $2.39 | $37,475 |
| Nov 17, 2025 | Galectin Therapeutics Inc. | Open-market sale | −15,680 | $6.04 | $94,707 |
| Nov 10, 2025 | Galectin Therapeutics Inc. | Option exercise | +1,867 | $2.39 | $4,462 |
| Nov 10, 2025 | Galectin Therapeutics Inc. | Open-market sale | −1,867 | $6.03 | $11,258 |
| Nov 5, 2025 | Galectin Therapeutics Inc. | Option exercise | +200 | $2.39 | $478 |
| Nov 5, 2025 | Galectin Therapeutics Inc. | Open-market sale | −200 | $6.00 | $1,200 |
| Nov 4, 2025 | Galectin Therapeutics Inc. | Option exercise | +14,420 | $2.39 | $34,464 |
Questions about Joel Lewis
What boards is Joel Lewis on?
Joel Lewis sits on the board of Galectin Therapeutics Inc.
What company is Joel Lewis the CEO of?
Joel Lewis is President and CEO of Galectin Therapeutics Inc.
How long has Joel Lewis served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.